Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

Go back to Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
(NASDAQ: ANAB) Delayed: 47.78 +2.35 (5.17%)
Previous Close $45.43    52 Week High $ 
Open $45.48    52 Week Low $ 
Day High $48.48    P/E N/A 
Day Low $45.48    EPS $ 
Volume 354,903